Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?

Abstract

INTRODUCTION Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate of all epithelial malignancies and a paradoxically rising incidence rate. Clinical translation of next generation sequencing (NGS) of tumour and germline samples may ameliorate outcomes by identifying prognostic and predictive genomic and transcriptomic features in… (More)
DOI: 10.1080/17474124.2017.1324296

Topics

Cite this paper

@article{Connor2017NextGS, title={Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?}, author={Ashton A. Connor and Steven Gallinger}, journal={Expert review of gastroenterology & hepatology}, year={2017}, volume={11 7}, pages={683-694} }